Fibroproliferative Remodeling of Immune‐Vascular Co‐Culture Spheroid Models in Response to Atherogenic Stimulation
Biotechnology and Bioengineering · 29.10.2026
DOI: 10.1002/bit.70435 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, online erschienen am 29.10.2026. Verfasst von Ibukunoluwa Naiyeju und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biological & Biomedical Engineering, McGill University, Montreal, Quebec, Canada. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Canada Research Chairs, Fonds de Recherche du Québec-Santé.
Abstract (Originalsprache)
Cell‐based models are highly valuable platforms for preclinical studies of atherosclerosis, offering controllable environments to investigate disease mechanisms. Three‐dimensional (3D) spheroids, a class of cell‐based models, enable the study of atherosclerotic disease phenomena under physiologically relevant yet controlled conditions. In this study, we examined the lipid‐induced changes in a co‐culture spheroid model comprising THP‐1‐derived macrophages and primary human coronary artery smooth muscle cells (HCASMCs) following treatment with 20 or 40 µg/mL oxidized LDL (ox‐LDL), a known atherogenic agent. Over a 10‐day period, we assessed changes in spheroid morphology (size and compactness), cell viability, metabolic activity, intracellular composition, gene expression, pro‐inflammatory cytokine release and extracellular matrix deposition, relative to the untreated control. Lipid exposure increased the abundance of macrophages in ox‐LDL‐treated spheroids (LS20‐3 h: 35.5 ± 21.9%; LS40‐3 h: 38.3 ± 8.7%) compared with controls (21.8 ± 0.7%) as early as day 3. Upregulation of fibronectin (LS20‐3 h: ~1.8‐fold; LS40‐3 h: ~2.1‐fold), CD36 (~1.8‐fold), and ABCA‐1 (~1.9‐fold) was also observed. Moreover, spheroids exposed to 40 µg/mL ox‐LDL exhibited reduced viability and compactness compared with those treated with 20 µg/mL by day 10. While lipid‐treated spheroids showed non‐statistically significantly higher levels of pro‐inflammatory IL‐1β cytokine expression at day 0 which declined (> 85% decrease) by day 3, all spheroid groups showed comparable global fibronectin ECM secretion indices. Collectively, these findings reveal lipid‐induced proliferative changes to spheroid composition & functionality and show their potential as biomimetic models for the study of atherosclerotic disease phenomena.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biological & Biomedical Engineering, McGill University, Montreal, Quebec, Canada.
- Lady Davis Institute for Medical Research, Montreal, Quebec, Canada.
- Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal, Quebec, Canada.
ORCID-Profile: Maryam Tabrizian
Förderung
- CIHR
- Canada Research Chairs
- Fonds de Recherche du Québec-Santé
- Canadian Institutes of Health Research
Zitieren
APA
Naiyeju, I., Lehoux, S., & Tabrizian, M. (2026). Fibroproliferative Remodeling of Immune‐Vascular Co‐Culture Spheroid Models in Response to Atherogenic Stimulation. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70435
Vancouver
Naiyeju I, Lehoux S, Tabrizian M. Fibroproliferative Remodeling of Immune‐Vascular Co‐Culture Spheroid Models in Response to Atherogenic Stimulation. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70435
BibTeX
@article{Naiyeju2026,
author = {Naiyeju, Ibukunoluwa and Lehoux, Stephanie and Tabrizian, Maryam},
title = {Fibroproliferative Remodeling of Immune‐Vascular Co‐Culture Spheroid Models in Response to Atherogenic Stimulation},
journal = {Biotechnology and Bioengineering},
year = {2026},
doi = {10.1002/bit.70435}
}
EUVIMED